-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120

Benzinga·11/05/2026 18:44:46
Listen to the news
Barclays analyst Christopher Pasquale maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $110 to $120.